Phathom Pharmaceuticals IncNASDAQ:PHAT
- LAST PRICE10.5000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 10.5000
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | PHAT |
|---|---|---|
| 09:32 ET | 3574 | 10.48 |
| 09:34 ET | 100 | 10.45 |
| 09:38 ET | 500 | 10.3 |
| 09:41 ET | 1100 | 10.3775 |
| 09:48 ET | 4750 | 10.225 |
| 09:50 ET | 557 | 10.2 |
| 09:52 ET | 800 | 10.18 |
| 09:54 ET | 5535 | 10.2 |
| 09:56 ET | 2400 | 10.19 |
| 09:57 ET | 494 | 10.185 |
| 09:59 ET | 200 | 10.16 |
| 10:01 ET | 1551 | 10.15 |
| 10:03 ET | 3712 | 10.1 |
| 10:06 ET | 300 | 10.14 |
| 10:08 ET | 588 | 10.1 |
| 10:10 ET | 300 | 10.11 |
| 10:12 ET | 7448 | 10.095 |
| 10:14 ET | 100 | 10.05 |
| 10:15 ET | 1764 | 10.1 |
| 10:17 ET | 1812 | 10.12 |
| 10:19 ET | 100 | 10.13 |
| 10:21 ET | 400 | 10.12 |
| 10:24 ET | 372 | 10.15 |
| 10:26 ET | 2400 | 10.18 |
| 10:30 ET | 6129 | 10.155 |
| 10:32 ET | 4616 | 10.16 |
| 10:33 ET | 890 | 10.21 |
| 10:35 ET | 2300 | 10.185 |
| 10:37 ET | 5427 | 10.215 |
| 10:42 ET | 2000 | 10.19 |
| 10:44 ET | 1308 | 10.18 |
| 10:46 ET | 1196 | 10.17 |
| 10:48 ET | 400 | 10.14 |
| 10:50 ET | 1000 | 10.18 |
| 10:55 ET | 100 | 10.15 |
| 10:57 ET | 1200 | 10.2 |
| 11:00 ET | 100 | 10.18 |
| 11:04 ET | 1500 | 10.17 |
| 11:08 ET | 100 | 10.16 |
| 11:09 ET | 100 | 10.17 |
| 11:11 ET | 100 | 10.15 |
| 11:13 ET | 535 | 10.14 |
| 11:15 ET | 343 | 10.12 |
| 11:18 ET | 900 | 10.165 |
| 11:20 ET | 100 | 10.14 |
| 11:24 ET | 175 | 10.17 |
| 11:26 ET | 100 | 10.19 |
| 11:31 ET | 200 | 10.19 |
| 11:33 ET | 15942 | 10.16 |
| 11:36 ET | 450 | 10.17 |
| 11:38 ET | 1100 | 10.2 |
| 11:40 ET | 9106 | 10.24 |
| 11:49 ET | 508 | 10.23 |
| 11:51 ET | 150 | 10.23 |
| 11:54 ET | 300 | 10.23 |
| 11:58 ET | 6458 | 10.225 |
| 12:00 ET | 500 | 10.23 |
| 12:02 ET | 600 | 10.24 |
| 12:03 ET | 3700 | 10.25 |
| 12:09 ET | 6820 | 10.24 |
| 12:12 ET | 1600 | 10.245 |
| 12:14 ET | 1431 | 10.2286 |
| 12:16 ET | 100 | 10.23 |
| 12:20 ET | 100 | 10.23 |
| 12:21 ET | 502 | 10.24 |
| 12:25 ET | 616 | 10.24 |
| 12:27 ET | 100 | 10.24 |
| 12:30 ET | 1340 | 10.24 |
| 12:32 ET | 10443 | 10.24 |
| 12:34 ET | 2450 | 10.2 |
| 12:36 ET | 100 | 10.215 |
| 12:39 ET | 200 | 10.215 |
| 12:43 ET | 100 | 10.215 |
| 12:45 ET | 300 | 10.215 |
| 12:48 ET | 200 | 10.215 |
| 12:50 ET | 100 | 10.215 |
| 12:54 ET | 200 | 10.215 |
| 12:57 ET | 100 | 10.23 |
| 12:59 ET | 100 | 10.23 |
| 01:01 ET | 2419 | 10.24 |
| 01:03 ET | 2149 | 10.24 |
| 01:06 ET | 355 | 10.24 |
| 01:08 ET | 490 | 10.24 |
| 01:10 ET | 600 | 10.25 |
| 01:12 ET | 100 | 10.25 |
| 01:14 ET | 914 | 10.2425 |
| 01:19 ET | 300 | 10.25 |
| 01:21 ET | 100 | 10.25 |
| 01:24 ET | 800 | 10.24 |
| 01:26 ET | 9823 | 10.2327 |
| 01:28 ET | 100 | 10.235 |
| 01:32 ET | 1000 | 10.24 |
| 01:33 ET | 100 | 10.23 |
| 01:35 ET | 100 | 10.235 |
| 01:37 ET | 100 | 10.235 |
| 01:39 ET | 100 | 10.23 |
| 01:44 ET | 1523 | 10.23 |
| 01:46 ET | 1600 | 10.22 |
| 01:48 ET | 4390 | 10.21 |
| 01:50 ET | 100 | 10.21 |
| 01:53 ET | 200 | 10.21 |
| 01:55 ET | 100 | 10.21 |
| 02:00 ET | 600 | 10.21 |
| 02:02 ET | 2385 | 10.22 |
| 02:08 ET | 300 | 10.22 |
| 02:09 ET | 8707 | 10.23 |
| 02:11 ET | 200 | 10.235 |
| 02:22 ET | 444 | 10.22 |
| 02:24 ET | 33444 | 10.31 |
| 02:26 ET | 3954 | 10.275 |
| 02:27 ET | 100 | 10.26 |
| 02:29 ET | 86857 | 10.25 |
| 02:31 ET | 1300 | 10.31 |
| 02:38 ET | 2794 | 10.35 |
| 02:40 ET | 4399 | 10.41 |
| 02:44 ET | 100 | 10.4 |
| 02:47 ET | 200 | 10.42 |
| 02:49 ET | 738 | 10.365 |
| 02:54 ET | 100 | 10.36 |
| 02:58 ET | 600 | 10.39 |
| 03:00 ET | 100 | 10.4 |
| 03:02 ET | 2088 | 10.35 |
| 03:03 ET | 6843 | 10.45 |
| 03:07 ET | 200 | 10.45 |
| 03:12 ET | 300 | 10.43 |
| 03:14 ET | 379 | 10.4275 |
| 03:18 ET | 100 | 10.4275 |
| 03:20 ET | 848 | 10.46 |
| 03:21 ET | 500 | 10.47 |
| 03:25 ET | 800 | 10.47 |
| 03:30 ET | 2921 | 10.5 |
| 03:32 ET | 300 | 10.52 |
| 03:34 ET | 100 | 10.52 |
| 03:36 ET | 200 | 10.505 |
| 03:38 ET | 300 | 10.52 |
| 03:39 ET | 11551 | 10.58 |
| 03:41 ET | 1621 | 10.565 |
| 03:43 ET | 666 | 10.55 |
| 03:45 ET | 700 | 10.52 |
| 03:48 ET | 879 | 10.505 |
| 03:50 ET | 1154 | 10.5 |
| 03:52 ET | 2513 | 10.54 |
| 03:54 ET | 1293 | 10.57 |
| 03:56 ET | 3484 | 10.54 |
| 03:57 ET | 1855 | 10.55 |
| 03:59 ET | 9492 | 10.5 |
May 24, 2024
DJ Phathom Pharmaceuticals Price Target Maintained With a $26.00/Share by Needham, from 12:46PM ET on Friday May 24, 2024 by Dow Jones
12:46PM ET on Friday May 24, 2024 by Dow Jones
May 17, 2024
DJ Phathom Pharmaceuticals Price Target Maintained With a $26.00/Share by Needham, from 10:04AM ET on Friday May 17, 2024 by Dow Jones
10:04AM ET on Friday May 17, 2024 by Dow Jones
May 15, 2024
Phathom Pharmaceuticals to Present VOQUEZNA(R) (vonoprazan) Data at DDW 2024 Annual Meeting, from 8:00AM ET on Wednesday May 15, 2024 by Dow Jones
8:00AM ET on Wednesday May 15, 2024 by Dow Jones
May 10, 2024
DJ Phathom Pharmaceuticals Price Target Maintained With a $26.00/Share by Needham, from 9:16AM ET on Friday May 10, 2024 by Dow Jones
9:16AM ET on Friday May 10, 2024 by Dow JonesDJ Phathom Pharmaceuticals Price Target Maintained With a $28.00/Share by HC Wainwright & Co., from 8:49AM ET on Friday May 10, 2024 by Dow Jones
8:49AM ET on Friday May 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Phathom Pharmaceuticals Inc | 614.6M | -2.4x | --- |
Mineralys Therapeutics Inc | 605.7M | -5.6x | --- |
Erasca Inc | 625.9M | -3.1x | --- |
Oculis Holding AG | 551.0M | -6.6x | --- |
Mind Medicine (MindMed) Inc | 591.5M | -2.8x | --- |
Hillevax Inc | 640.9M | -3.9x | --- |
Company Information
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases. The Company’s pipeline product candidate, VOQUEZNA, VOQUEZNA TRIPLE PAK, and VOQUEZNA DUAL PAK. Its product candidate, VOQUEZNA, contains vonoprazan, an oral small molecule potassium-competitive acid blocker (PCAB). PCABs are a novel class of medicines that block acid secretion in the stomach. Vonoprazan has also demonstrated clinical benefits in the treatment of erosive gastroesophageal reflux disease (erosive GERD), and in combination with antibiotics for the treatment of Helicobacter pylori (H. pylori) infection. GERD and H. pylori infection are two of the most common acid-related GI diseases. GERD is a disease that develops when the reflux of acidic stomach contents causes troublesome symptoms and/or complications. H. pylori is a bacterial pathogen.
Contact Information
- Headquarters
- 100 Campus Drive, Suite 102FLORHAM PARK, NJ, United States 07932
- Phone
- 302-636-5400
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Michael Cola
- President, Chief Executive Officer, Director
- Terrie Curran
- Co-Founder, Chief Operating Officer
- Azmi Nabulsi
- Co-Founder, Director
- David Socks
- Chief Financial Officer and Business Officer
- Molly Henderson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $614.6M |
|---|---|
Revenue (TTM) | $2.6M |
Shares Outstanding | 58.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.70 |
EPS | $-4.41 |
Book Value | $-1.26 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | 236.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -7,987.24% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
